Searchable abstracts of presentations at key conferences in endocrinology

ea0011p721 | Reproduction | ECE2006

Serum Anti-Mullerian hormone (AMH) concentrations in infants and children

Wilson G , Fleming R , Galloway P , Wallace AM , Ahmed SF

Introduction: AMH is produced by the sertoli cells in the testes and is responsible for the regression of the Mullerian structures in the male fetus. It is also produced by the granulosa cells of the ovaries in females to a lesser degree. Serum AMH measurements may be important for detecting testicular tissue and monitoring ovarian activity. The objective of this study was to establish a cross-sectional reference range for AMH in UK children.Method: Seru...

ea0033p1 | (1) | BSPED2013

Plasma cortisol levels and adrenal weight in cases of death in childhood

Morrison R. , Khan J , Galloway P , McNeilly J , Penman D , Ahmed S F

Introduction: The incidence of adrenal insufficiency in cases of unexplained death in young children is unclear. It is also unclear whether there is a relationship between adrenal size and plasma cortisol concentration.Methods: All post-mortem (PM) reports of sudden deaths in children in the West of Scotland between 2010 and 2012 were retrospectively analysed. Combined adrenal weight (g) was recorded and expressed as the percentage of total body weight (...

ea0019p290 | Reproduction | SFEBES2009

Serum anti-Mullerian hormone and The HCG stimulation test for investigating boys with disorders of sex development

Keir L , Ahmed S , McNeilly J , Galloway P , O'Toole S , Wallace A

Background: In XY disorders of sex development, a single measurement of serum Anti-Mullerian hormone (AMH) may replace the hCG stimulation test.Aim: To assess the level of concordance between serum AMH and hCG stimulated testosterone concentrations.Methods: About 284 children (M:F,154:130) with a median age of 8 years (10th, 90th centiles, 0.25,14) were used to establish a normal reference range for AMH. Clinical data were reviewed...

ea0030p51 | (1) | BSPED2012

Growth and glucose homeostasis after 2 years in children with inflammatory bowel disease receiving recombinant GH therapy for growth retardation

Towati Mabrouka A L , Wong S C , Galloway P J , Hassan K , Russell R K , McGrogan P , Ahmed S F

Background: A recent RCT of rhGH in IBD over 6 months showed that improvement in linear growth was associated with a reduction in insulin sensitivity.Objectives: To investigate the effects of prolonged rhGH on growth and glucose homeostasis in children with IBD.Patients and methods: Eleven children (10CD/1UC) (9 m) with a median age of 14.7 years (range, 8.9, 16.2) who received rhGH (0.067 mg/kg per day) as part a 6-month RCT were ...